Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Charles B. Nemeroff, MD, PhD: Duloxetine for the Treatment of Major Depressive Disorder
1
x
$
30.00
Psychopharmacology Bulletin VOL 49 No. 1, 2019 - Full Issue Stacked PDF
1
x
$
90.00
Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study
1
x
$
30.00
Trisha Suppes, MD, PhD: Awareness of Metabolic Concerns and Perceived Impact of Pharmacotherapy in Patients with Bipolar Disorder: A Survey of 500 US Psychiatrists
1
x
$
30.00
Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology
1
x
$
30.00
ADHD-A Clinician’s Bird’s Eye View of Current Status and New Vistas!
1
x
$
30.00
Economics of Cancer Drug Development
1
x
$
0.00
View Cart
Checkout
Home
drug-development
“Economics of Cancer Drug Development” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Jay D. Kranzler, MD, PhD: The Psychopharmacology of Fibromyalgia: A Drug Development Perspective
$
30.00
Add to cart
Details
Cara L. Alfaro, PharmD: Emerging Role of Drug Interaction Studies in Drug Development:The Good, the Bad, and the Unknown
$
30.00
Add to cart
Details
Economics of Cancer Drug Development
$
0.00
Add to cart
Details
OPEN ACCESS: Serotonergic Drugs for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Review of Past Development, Pitfalls and Failures, and a Look to the Future
$
0.00
Add to cart
Details
Page load link
Go to Top
